Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
Aegerion Pharmaceuticals Reaches Settlement Agreements in Principle with…
Aegerion Pharmaceuticals has reached agreements in principle with the Department of Justice ("DOJ") and the Securities and…
Pfizer/Wyeth Settlement Finalized and Signed: States Net Millions
The Department of Justice ("DOJ") recently entered into a settlement of a quit tam lawsuit against Pfizer, Inc. and…
Toussaint Found Guilty: Faces 70 Years in Prison and Millions in Fines
Richard Toussaint, best known as a Dallas, Texas anesthesiologist and the co-founder of the recently-bankrupt hospital…
Tenet Healthcare Settlement Offer
Tenet has been locked in a legal battle against allegations that four of its hospitals violated the Anti-Kickback Statute and the…
Olympus Settlement and Corporate Integrity Agreement – FCPA and Anti…
The United States Department of Justice has announced a settlement with medical device maker Olympus, to the tune of…
Pfizer Reaches “Agreement in Principle” for Wyeth Whistleblower Case for…
Pfizer and the United States government reached an "agreement in principle" on February 16, 2016 regarding two…
2016 The Year of Pharmacy Enforcement
For some time now, both the U.S. Department of Justice ("DOJ") and the Drug Enforcement Administration ("DEA") have…
DOJ Becoming Comfortable With Permitting Truthful, Non-misleading Promotion
As we know all too well, the U.S. Food and Drug Administration (FDA) has long taken the position that a medical device…
Novartis Settlement and Corporate Integrity Agreement Amendment
We have previously written about the proposed Novartis AG settlement relating its False Claims Act suit. The suit…
States Target Compounding Pharmacies over Claims to Military Health Program
Federal prosecutors in at least four states – Florida, California, Texas, and Mississippi – are ramping up…